IX-01 clinical trials
Also written IX-01.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses IX-01 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- IX-01
- 4
Studies by the year they started
6 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Ixchelsis Limited (6)
Studies
Open first, then newest update. How each study uses IX-01 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy MenCompletedPhase 1Ixchelsis LimitedNCT02139826Written as IX-01
- IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)CompletedPhase 2Ixchelsis LimitedNCT02232425Written as IX-01
- IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)CompletedPhase 2Ixchelsis LimitedNCT03055806Written as IX-01 400 mg
- Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy MalesCompletedPhase 1Ixchelsis LimitedNCT02962531Written as IX-01 caplets 1600 mg (4 x 400 mg), fasted
- A Study of Multiple Oral Doses of IX-01 in Healthy Male SubjectsCompletedPhase 1Ixchelsis LimitedNCT02792647Written as IX-01
- A Study of Multiple Oral Doses of IX-01 in Healthy MenCompletedPhase 1Ixchelsis LimitedNCT01994083Written as IX-01